{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:34:29Z","timestamp":1783344869071,"version":"3.54.6"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00499","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:31:05Z","timestamp":1522125065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Paola","family":"De Cicco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Maloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ianaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1159\/000330913","article-title":"Innate immune activation in intestinal homeostasis","volume":"3","author":"Harrison","year":"2011","journal-title":"J Innate Immun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1471-4906(03)00132-7","article-title":"l-arginine metabolism in myeloid cells controls T-lymphocyte functions","volume":"24","author":"Bronte","year":"2003","journal-title":"Trends Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1097\/MIB.0b013e3182902b11","article-title":"Myeloid-derived suppressor cells in the inflammatory bowel diseases","volume":"19","author":"Ostanin","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/mi.2010.61","article-title":"Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer","volume":"4","author":"Fox","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.20021345","article-title":"CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms","volume":"197","author":"Maloy","year":"2003","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1096\/fj.07-8669com","article-title":"Hydrogen sulfide enhances ulcer healing in rats","volume":"21","author":"Wallace","year":"2007","journal-title":"FASEB J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/j.gastro.2009.04.012","article-title":"Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats","volume":"137","author":"Wallace","year":"2009","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"G467","DOI":"10.1152\/ajpgi.00169.2013","article-title":"Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments","volume":"305","author":"Chan","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s10620-017-4681-0","article-title":"Gaseous mediators in gastrointestinal mucosal defense and injury","volume":"62","author":"Wallace","year":"2017","journal-title":"Dig Dis Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fphys.2016.00156","article-title":"Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases","volume":"7","author":"Guo","year":"2016","journal-title":"Front Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.phrs.2016.07.041","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer","volume":"111","author":"Ianaro","year":"2016","journal-title":"Pharmacol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"57077","DOI":"10.18632\/oncotarget.10976","article-title":"Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival","volume":"7","author":"Panza","year":"2016","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1073\/pnas.0705710104","article-title":"Hydrogen sulfide mediates the vasoactivity of garlic","volume":"104","author":"Benavides","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcmgh.2014.11.006","article-title":"Mechanisms of immune signaling in colitis-associated cancer","volume":"1","author":"Waldner","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway","volume":"135","author":"Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e70828","DOI":"10.1371\/journal.pone.0070828","article-title":"Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1189\/jlb.0113050","article-title":"The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis","volume":"94","author":"Guan","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2010.00744.x","article-title":"Could Helicobacter organisms cause inflammatory bowel disease?","volume":"61","author":"Hansen","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.redox.2015.10.006","article-title":"Antioxidant therapy for treatment of inflammatory bowel disease: does it work?","volume":"6","author":"Moura","year":"2015","journal-title":"Redox Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6043038","DOI":"10.1155\/2016\/6043038","article-title":"Hydrogen sulfide and cellular redox homeostasis","volume":"2016","author":"Xie","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13559","DOI":"10.1073\/pnas.1413390111","article-title":"Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis","volume":"111","author":"Flannigan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0147289","DOI":"10.1371\/journal.pone.0147289","article-title":"Profound chemopreventative effects of a hydrogen sulfide-releasing NSAID in the APCMin\/+ mouse model of intestinal tumorigenesis","volume":"11","author":"Paul-Clark","year":"2016","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/ars.2010.3781","article-title":"The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues","volume":"15","author":"Kabil","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/jb\/mvp111","article-title":"Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide","volume":"146","author":"Shibuya","year":"2009","journal-title":"J Biochem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/ARS.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41467-017-01311-y","article-title":"Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics","volume":"8","author":"Akaike","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/ja1085723","article-title":"Cysteine-activated hydrogen sulfide (H2S) donors","volume":"133","author":"Zhao","year":"2011","journal-title":"J Am Chem Soc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.1039\/c4cc00968a","article-title":"Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications","volume":"50","author":"Zhao","year":"2014","journal-title":"Chem Commun (Camb)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1021\/acs.orglett.5b01962","article-title":"Diallyl trisulfide is a fast H2S donor, but diallyl disulfide is a slow one: the reaction pathways and intermediates of glutathione with polysulfides","volume":"17","author":"Liang","year":"2015","journal-title":"Org Lett"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1039\/c5mb00216h","article-title":"Persulfides: current knowledge and challenges in chemistry and chemical biology","volume":"11","author":"Park","year":"2015","journal-title":"Mol Biosyst"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1021\/acs.jpcb.7b03683","article-title":"Computational study of H2S release in reactions of diallyl polysulfides with thiols","volume":"121","author":"Cai","year":"2017","journal-title":"J Phys Chem B"},{"key":"B44","doi-asserted-by":"publisher","first-page":"803; author reply 803","DOI":"10.1038\/nrm3391-c2","article-title":"The conversion of H(2)S to sulfane sulfur","volume":"13","author":"Toohey","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2014.08.003","article-title":"Isotope dilution mass spectrometry for the quantification of sulfane sulfurs","volume":"76","author":"Liu","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"12789","DOI":"10.3390\/molecules190812789","article-title":"Thiosulfoxide (sulfane) sulfur: new chemistry and new regulatory roles in biology","volume":"19","author":"Toohey","year":"2014","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"R1212","DOI":"10.1152\/ajpregu.00061.2016","article-title":"Garlic oil polysulfides: H2S- and O2-independent prooxidants in buffer and antioxidants in cells","volume":"310","author":"DeLeon","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1093\/carcin\/bgm180","article-title":"Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma","volume":"28","author":"Poutahidis","year":"2007","journal-title":"Carcinogenesis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1073\/pnas.0812347106","article-title":"Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice","volume":"106","author":"Erdman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.4049\/jimmunol.171.3.1484","article-title":"NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40","volume":"171","author":"Tomczak","year":"2003","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4049\/jimmunol.176.2.1244","article-title":"Defective activation of ERK in macrophages lacking the p50\/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus","volume":"176","author":"Tomczak","year":"2006","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2012.11.006","article-title":"Redox biology of hydrogen sulfide: implications for physiology, pathophysiology, and pharmacology","volume":"1","author":"Stein","year":"2013","journal-title":"Redox Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00499\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:31:07Z","timestamp":1522125067000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00499\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2018.00499"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00499","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"article-number":"499"}}